Biolife Sciences (Biolife Sciences) EBIT per Share : $-39.20 (TTM As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences EBIT per Share?

Biolife Sciences's EBIT per Share for the three months ended in May. 2008 was $16.80. Its EBIT per Share for the trailing twelve months (TTM) ended in May. 2008 was $-39.20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Biolife Sciences's EBIT per Share or its related term are showing as below:

BLFE's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 5.6
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Biolife Sciences's EBIT for the three months ended in May. 2008 was $0.08 Mil.

Biolife Sciences EBIT per Share Historical Data

The historical data trend for Biolife Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences EBIT per Share Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

EBIT per Share

-21.00

-263.50

7.50

19.50

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
EBIT per Share	Get a 7-Day Free Trial										80.00	5.00	-33.00	-28.00	16.80

Biolife Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Biolife Sciences's EBIT per Share for the fiscal year that ended in Nov. 2007 is calculated as

	EBIT per Share		(A: Nov. 2007 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.039	/	0.002
=	19.50

Biolife Sciences's EBIT per Share for the quarter that ended in May. 2008 is calculated as

	EBIT per Share		(Q: May. 2008 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.084	/	0.005
=	16.80

EBIT per Share for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-39.20

Biolife Sciences (OTCPK:BLFE) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Biolife Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020